PMID- 31202680 OWN - NLM STAT- MEDLINE DCOM- 20200302 LR - 20200302 IS - 1535-7732 (Electronic) IS - 1051-0443 (Linking) VI - 30 IP - 11 DP - 2019 Nov TI - Experience with Compressed Gelfoam Plugs in Children during Liver Biopsies and Other IR Procedures: A Retrospective Single-Center Case Series. PG - 1855-1862 LID - S1051-0443(19)30370-7 [pii] LID - 10.1016/j.jvir.2019.04.004 [doi] AB - PURPOSE: To analyze the experience using compressed gelfoam plugs (CGPs) in children during liver biopsies and other interventional procedures. MATERIALS AND METHODS: This was a single-center, retrospective, consecutive case series of 477 various pediatric interventional radiology procedures using CGPs (January 2012 to December 2016) performed on 397 children (209 males, 188 females; median age, 7 years [range, 9 days-17.8 years]; median weight, 18 kg [range, 2.7-141 kg]). Of 477 procedures, most (n = 371) were liver biopsies, 98 were biopsies of other organs, and 8 were non-biopsy procedures. Analysis focused on liver biopsies. RESULTS: Of liver biopsies, a median of 2 CGPs were used per procedure, and the mean drop in hemoglobin was -0.36 g/dl (-3.0% change). Thirty-seven mild, 8 moderate, 2 severe, and 1 life-threatening (an anaphylaxis to CGP) adverse events (AEs) occurred. Analysis of liver biopsies with AEs showed significant association between number of passes, cores, and focal-type lesions (unadjusted logistic regression: P = .007, P = .022, P = .028, respectively) and age, weight, and number of passes (adjusted multiple logistic regression: P = .006, P = .032, P = .046, respectively). Technical problems relating to CGP deployment were noted in 5 (1%), without any AEs. CONCLUSIONS: CGPs were used in a wide variety of procedures and organs in children. There was 1 life-threatening AE resulting from the rare risk of anaphylaxis caused by the gelfoam-containing plug. After liver biopsies, transfusion was required in 2/371 (0.5%) procedures, 1 related to pre-biopsy anemia (0.25%). CI - Copyright (c) 2019 SIR. Published by Elsevier Inc. All rights reserved. FAU - McDonald, Julian AU - McDonald J AD - Department of Diagnostic Imaging, Division of Image Guided Therapy, The Hospital for Sick Children, University of Toronto, 555 University Avenue, Toronto, ON, M5G 1X8, Canada; University of Edinburgh Medical School, Edinburgh, United Kingdom. Electronic address: julianmnmcdonald@gmail.com. FAU - Amirabadi, Afsaneh AU - Amirabadi A AD - Department of Diagnostic Imaging, Division of Image Guided Therapy, The Hospital for Sick Children, University of Toronto, 555 University Avenue, Toronto, ON, M5G 1X8, Canada. FAU - Farhat, Ziad AU - Farhat Z AD - Department of Diagnostic Imaging, IWK Health Centre, Dalhousie University Faculty of Medicine, Halifax, Canada. FAU - Temple, Michael AU - Temple M AD - Department of Diagnostic Imaging, Division of Image Guided Therapy, The Hospital for Sick Children, University of Toronto, 555 University Avenue, Toronto, ON, M5G 1X8, Canada. FAU - Parra, Dimitri AU - Parra D AD - Department of Diagnostic Imaging, Division of Image Guided Therapy, The Hospital for Sick Children, University of Toronto, 555 University Avenue, Toronto, ON, M5G 1X8, Canada. FAU - Amaral, Joao AU - Amaral J AD - Department of Diagnostic Imaging, Division of Image Guided Therapy, The Hospital for Sick Children, University of Toronto, 555 University Avenue, Toronto, ON, M5G 1X8, Canada. FAU - Connolly, Bairbre AU - Connolly B AD - Department of Diagnostic Imaging, Division of Image Guided Therapy, The Hospital for Sick Children, University of Toronto, 555 University Avenue, Toronto, ON, M5G 1X8, Canada. LA - eng PT - Journal Article DEP - 20190613 PL - United States TA - J Vasc Interv Radiol JT - Journal of vascular and interventional radiology : JVIR JID - 9203369 SB - IM MH - Adolescent MH - Age Factors MH - Anaphylaxis/chemically induced MH - Biopsy, Large-Core Needle MH - Child MH - Child, Preschool MH - Female MH - Gelatin Sponge, Absorbable/*administration & dosage/adverse effects MH - Hemorrhage/etiology/*prevention & control MH - Humans MH - *Image-Guided Biopsy/adverse effects MH - Infant MH - Infant, Newborn MH - Liver Diseases/*pathology MH - Male MH - Ontario MH - *Radiography, Interventional/adverse effects MH - Retrospective Studies MH - Risk Assessment MH - Risk Factors MH - Treatment Outcome EDAT- 2019/06/17 06:00 MHDA- 2020/03/03 06:00 CRDT- 2019/06/17 06:00 PHST- 2018/10/27 00:00 [received] PHST- 2019/03/09 00:00 [revised] PHST- 2019/04/02 00:00 [accepted] PHST- 2019/06/17 06:00 [pubmed] PHST- 2020/03/03 06:00 [medline] PHST- 2019/06/17 06:00 [entrez] AID - S1051-0443(19)30370-7 [pii] AID - 10.1016/j.jvir.2019.04.004 [doi] PST - ppublish SO - J Vasc Interv Radiol. 2019 Nov;30(11):1855-1862. doi: 10.1016/j.jvir.2019.04.004. Epub 2019 Jun 13.